Lesley C. Lomo
No Rating Available
(Learn About Our Rating System)

Lesley C. Lomo, MD, MS

Languages spoken: English

  • Surgical Pathologist and Cytopathologist with subspecialty expertise in gynecologic and breast surgical pathology and fine needle aspiration cytopathology. Additional interests include undergraduate and graduate medical education in pathology.

    Specialties

    • Breast Pathology
    • Cytopathology
    • Gynecologic Pathology
    • Pathology, Anatomical

    Board Certification

    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Cytopathology)

  • Surgical Pathologist and Cytopathologist with subspecialty expertise in gynecologic and breast surgical pathology and fine needle aspiration cytopathology. Additional interests include undergraduate and graduate medical education in pathology.

    Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Board Certification
    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Cytopathology)

    Education history

    Chief Resident Anatomic Pathology - Brigham and Women’s Hospital Chief Resident
    Breast Pathology - Brigham and Women’s Hospital Fellow
    Fellowship Cytopathology - Brigham and Women’s Hospital Fellow
    Gynecologic Pathology - Brigham and Women’s Hospital Fellow
    Residency Anatomic and Clinical Pathology - Brigham and Women’s Hospital Resident
    Medicine - Wayne State University School of Medicine M.D.
    Graduate Training Basic Medical Sciences - Wayne State University School of Medicine M.S.
    English - University of Michigan B.A.

    Selected Publications

    Journal Article

    1. Balatico M, Ruano AL, Cleary AS, Lomo L, Gulbahce HE (2023). Male Invasive Lobular Breast Cancer: Clinicopathologic Features Including Recurrence Score Results From a Population-Based Database. Arch Pathol Lab Med, 148(3), 263-264. (Read full article)
    2. Schmidt RL, White SK, Timme KH, McFarland MM, Lomo LC (2023). Graduate Medical Education in Pathology: A Scoping Review. Arch Pathol Lab Med, 148(1), 117-127. (Read full article)
    3. McMurtry V, Cleary AS, Ruano AL, Lomo L, Gulbahce HE (2023). Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database. Am J Clin Oncol, 46(12), 559-566. (Read full article)
    4. Harris CK, Chen Y, Alston EL, Brown A, Chabot-Richards D, Dintzis SM, Graber ML, Jackups R Jr, Lomo LC, Laudadio J, Markwood PS, Nielson KJ, Samedi V, Sampson B, Haspel RL, Zafar N, Montone KT, Childs J, White KL, Heher YK (2023). The next phase in patient safety education: Towards a standardized, tools-based pathology patient safety curriculum: A call to action from the Association of Pathology Chairs' Residency Program Directors Section Training Residents in Patient Safety Workgroup. Acad Pathol, 10(2), 100081. (Read full article)
    5. Wilcock DM, Moore KH, Rowe L, Mahlow J, Jedrzkiewicz J, Cleary AS, Lomo L, Ruano AL, Gering M, Bradshaw D, Maughan M, Tran P, Burlingame J, Davis R, Affolter K, Albertson DJ, Adelhardt P, Kim JT, Coleman JF, Deftereos G, Gulbahce EH, Sirohi D (2023). Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast Cancer. Arch Pathol Lab Med. (Read full article)
    6. McMurtry V, Mahlow J, Coleman JF, Deftereos G, Jattani R, Bastien RRL, Durtschi J, Jarboe E, Lomo L, Sirohi D (2022). Morphologic Characteristics and Mutational Analysis of Fumarate Hydratase Deficient Kidney and Smooth Muscle Tumors. Am J Clin Pathol, 159(2), 164-171. (Read full article)
    7. Garg D, Hodgman M, Reil S, Lomo L, Aston KI, Hill J, Johnstone E, Jenkins T, Letourneau JM (2022). Effect of chemotherapy on the uterus of young adult cancer survivors. F S Rep, 3(3), 198-203. (Read full article)
    8. Garg D, Johnstone EB, Lomo L, Fair DB, Rosen MP, Taylor R, Silver B, Letourneau JM (2020). Looking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments. J Assist Reprod Genet, 37(6), 1467-1476. (Read full article)
    9. Blair CK, Wiggins CL, Nibbe AM, Storlie CB, Prossnitz ER, Royce M, Lomo LC, Hill DA (2019). Obesity and survival among a cohort of breast cancer patients is partially mediated by tumor characteristics. NPJ Breast Cancer, 5, 33. (Read full article)
    10. Brocato TA, Brown-Glaberman U, Wang Z, Selwyn RG, Wilson CM, Wyckoff EF, Lomo LC, Saline JL, Hooda-Nehra A, Pasqualini R, Arap W, Brinker CJ, Cristini V (2019). Predicting breast cancer response to neoadjuvant chemotherapy based on tumor vascular features in needle biopsies. JCI Insight, 5. (Read full article)

    Review

    1. Sama S, Rosqvist S, Savage T, Lomo L, Sibbald K, Straubhar A, Werner TL (2024). Durable response to BRAF inhibitor monotherapy in recurrent metastatic low grade serous ovarian cancer. [Review]. Gynecol Oncol Rep, 53, 101412. (Read full article)